Private placement of equity in BioInvent International AB (SE) — SEK 194 million

Carnegie acted as lead manager in the private placement of equity in BioInvent International AB. By use of its technology platform BioInvent International AB is a partner to pharmaceutical companies within therapeutic antibodies and antibodies for use as discovery tools.April, 2000.